AU2001268467A1 - Identification of genes and compounds for treatment of cancer - Google Patents
Identification of genes and compounds for treatment of cancerInfo
- Publication number
- AU2001268467A1 AU2001268467A1 AU2001268467A AU6846701A AU2001268467A1 AU 2001268467 A1 AU2001268467 A1 AU 2001268467A1 AU 2001268467 A AU2001268467 A AU 2001268467A AU 6846701 A AU6846701 A AU 6846701A AU 2001268467 A1 AU2001268467 A1 AU 2001268467A1
- Authority
- AU
- Australia
- Prior art keywords
- genes
- cancer
- identification
- compounds
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59348800A | 2000-06-14 | 2000-06-14 | |
| US09/593,488 | 2000-06-14 | ||
| PCT/US2001/019248 WO2001096606A2 (fr) | 2000-06-14 | 2001-06-14 | Identification de genes et de composes pour le traitement du cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001268467A1 true AU2001268467A1 (en) | 2001-12-24 |
Family
ID=24374909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001268467A Abandoned AU2001268467A1 (en) | 2000-06-14 | 2001-06-14 | Identification of genes and compounds for treatment of cancer |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001268467A1 (fr) |
| WO (1) | WO2001096606A2 (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR060702A1 (es) * | 2007-04-27 | 2008-07-10 | Fundacion Inst Leloir | Promotor inducible por especies reactivas del oxigeno y vector que lo comprende |
| CN102186883B (zh) | 2008-09-18 | 2016-08-03 | 西北大学 | Nmda受体调节剂和其用途 |
| US8951968B2 (en) | 2009-10-05 | 2015-02-10 | Northwestern University | Methods of treating depression and other related diseases |
| SG183265A1 (en) | 2010-02-11 | 2012-09-27 | Univ Northwestern | Secondary structure stabilized nmda receptor modulators and uses thereof |
| KR101692275B1 (ko) | 2010-02-11 | 2017-01-04 | 노오쓰웨스턴 유니버시티 | ２차 구조 안정화된 ｎｍｄａ 수용체 조절제 및 그의 용도 |
| MX375286B (es) | 2013-01-29 | 2025-03-06 | Aptinyx Inc | Moduladores de receptores nmda de espiro-lactama y sus usos. |
| PE20151438A1 (es) | 2013-01-29 | 2015-10-10 | Naurex Inc | Moduladores de receptores nmda de espiro-lactama y sus usos |
| CN105229011B (zh) | 2013-01-29 | 2018-02-06 | 阿普廷伊克斯股份有限公司 | 螺‑内酰胺nmda受体调节剂及其用途 |
| ES2618421T3 (es) | 2013-01-29 | 2017-06-21 | Aptinyx Inc. | Moduladores espiro-lactama del receptor NMDA y usos de los mismos |
| CA2898863A1 (fr) | 2013-01-29 | 2014-08-07 | Naurex, Inc. | Modulateurs spirolactames d'un recepteur nmda et leurs utilisations |
| WO2017201285A1 (fr) | 2016-05-19 | 2017-11-23 | Aptinyx Inc. | Modulateurs spirolactames des récepteurs nmda et leurs utilisations |
| CA3024606C (fr) | 2016-05-19 | 2019-09-03 | Aptinyx Inc. | Modulateurs de recepteurs nmda de spiro-lactame et utilisations associees |
| US11028095B2 (en) | 2016-08-01 | 2021-06-08 | Aptinyx Inc. | Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereof |
| JP2019527232A (ja) | 2016-08-01 | 2019-09-26 | アプティニックス インコーポレイテッド | スピロ−ラクタムｎｍｄａ修飾因子及びこれを用いた方法 |
| JP7036792B2 (ja) | 2016-08-01 | 2022-03-15 | アプティニックス インコーポレイテッド | スピロ－ラクタムｎｍｄａ受容体修飾因子およびその使用 |
| WO2018026782A1 (fr) | 2016-08-01 | 2018-02-08 | Aptinyx Inc. | Modulateurs spirolactames des récepteurs nmda et leurs utilisations |
| US11299495B2 (en) | 2016-08-01 | 2022-04-12 | Aptinyx Inc. | Spiro-lactam NMDA receptor modulators and uses thereof |
| US11578072B2 (en) | 2018-01-31 | 2023-02-14 | Aptinyx Inc. | Spiro-lactam NMDA receptor modulators and uses thereof |
| US12012413B2 (en) | 2019-11-11 | 2024-06-18 | Tenacia Biotechnology (Hong Kong) Co., Limited | Methods of treating painful diabetic peripheral neuropathy |
-
2001
- 2001-06-14 AU AU2001268467A patent/AU2001268467A1/en not_active Abandoned
- 2001-06-14 WO PCT/US2001/019248 patent/WO2001096606A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001096606A2 (fr) | 2001-12-20 |
| WO2001096606A3 (fr) | 2003-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002307217A1 (en) | Materials and methods for treatment of cancer and identification of anti-cancer compounds | |
| AU2001268467A1 (en) | Identification of genes and compounds for treatment of cancer | |
| AU2002219472A1 (en) | Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens | |
| AU2001229340A1 (en) | Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU2001236519A1 (en) | Identification, assessment, prevention, and therapy of prostate cancer | |
| AU2002328952A1 (en) | Irinotecan for treatment of cancer | |
| EP1176964B8 (fr) | Utilisation du compose et743 pour le traitement du cancer | |
| AUPQ923100A0 (en) | Treatment of prostate cancer | |
| AU2002239491A1 (en) | Methods for the treatment of cancer and other diseases and methods of developing the same | |
| AU2001251613A1 (en) | Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers | |
| AU2001266838A1 (en) | Inhibitors of matriptase for the treatment of cancer | |
| AU2002313426A1 (en) | Tumor antigens for prevention and/or treatment of cancer | |
| AU2001253836A1 (en) | Method of treating cancer | |
| AU4369800A (en) | Treatment of metastatic cancer through mts-1 gene | |
| AU2001232060A1 (en) | Use of cyp1b1 inhibitors for treating cancer | |
| AU2001257325A1 (en) | Cancer treatment | |
| AU2001241779A1 (en) | Method of treatment of prostate cancer | |
| AU7636800A (en) | Improved ricin-like toxins for treatment of cancer | |
| AU2001245414A1 (en) | Treatment of allergies | |
| AU2001278738A1 (en) | Medicinal compositions for preventing and treating cancer | |
| AU2002337713A1 (en) | Pharmaceutical compositions and methods for treating cancer | |
| AU2002251367A1 (en) | Proteins and genes for diagnosis and treatment of erbb2-related cancer | |
| AU5552400A (en) | Treatment of cancer | |
| AUPQ367699A0 (en) | Treatment of cancer | |
| AUPR644301A0 (en) | Method and composition for treatment of cancer |